Company intelligence / Profile preview

Tissue Engineering Technologies

Alachua, Florida, United States

Ownership: Private
Development stage: Other

Overview

Tissue Engineering Technologies (TET) was a biotechnology company focused on the development of advanced regenerative medicine products for bone and tissue repair. The company specialized in creating bioactive scaffolds and cell-based therapies designed to promote natural healing in orthopedic and dental applications. Its primary focus was on the commercialization of bone graft substitutes and tissue engineering solutions that integrate with the patient's own biological processes. The company was eventually acquired, and its technologies were integrated into the portfolio of a larger medical device manufacturer.

Therapeutic areas: RheumatologyOther
Modalities: Cell therapyDeviceBiologic
Industry: Biotech

Beyond the preview

Go deeper on Tissue Engineering Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue Engineering Technologies.

Explore the full profile